Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-05-07

Clinical Trial Update: Levemir-Body Composition and Energy Metabolism [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating insulin detemir (Levemir) for effects on body composition and energy metabolism in individuals with Type 2 diabetes mellitus…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Levemir (insulin detemir)

Snippet

Sponsor: Institut de Recherches Cliniques de Montreal | Conditions: Type 2 Diabetes | Phase 4 | Status: COMPLETED